Vaccine Manufacturing Forum
October 24-25, 2018 | Grosvenor House West Marina Beach, Dubai, UAE
Merck invites you to the Vaccine Manufacturing Forum to empower and accelerate local vaccine development and manufacturing in Africa and Middle East.
Meet vaccine manufacturing experts and business partners to:
For more information, please contact PSCommercialServiceXP@merckgroup.com
We look forward to welcoming you.
Agenda*
Day 1 - October 24th
Welcome and opening remarks
- Dr Anissa Boumlic, Associate Director Vaccines & Viral Therapies Segment, Process Solutions
Vaccine development and manufacturing in Africa and Middle East status, challenges and opportunities
- Pr. William Ampofo, University of Accra & African vaccine manufacturers initiative, Ghana
- Patrick Tippo, Head Science and Innovation, The Biovac Institute & African vaccine manufacturers initiative, South Africa
- Dr Mehdi El Harrak, R&D Director, MCI Santé Animale, Morocco
- Dr Mazen Hassanain, Managing Director of Saudi Vaccine & Biomanufacturing Project, Research Products Development Company (RPDC) & King Saud University, Saudi Arabia
Establishing new vaccine facilities: requirements, regulatory framework, initiatives and case studies
- Dr Morena Makhoana, CEO, The Biovac Institute, South Africa
- Kristopher Howard, Managing Director, NRL Solutions/UNIDO, Ireland
- Dr Simon Agwale, CEO, Innovative Biotech Ltd, Nigeria
- Speaker from ASPIRx, Ghana (TBC)
Integrating single-use technologies in the manufacturing of vaccines
- Dr Zahia Hannas, R&D & Industrialization Director, BI Animal Health, France
- Nathalie Robinau, Yellow Fever Vaccine Department Director, Pasteur Institute Dakar, Senegal
- Dr Leonid Duklinov, Site Director, ME-VAC, Egypt
- Dr Anissa Boumlic, Associate Director Vaccines & Viral Therapies Segment, Process Solutions
Networking cocktail and dinner
Day 2 - October 25th
Collaborations and tech transfers to accelerate vaccine manufacturing growth
- Dr Davinder Gill, CEO, Hilleman Laboratories, India
- Dr Yacine Sellam, Head of Vaccines Projects & Public Private partnerships, Institute Pasteur Algiers, Algeria
- Speaker from Developing Countries Vaccine Manufacturing Network (DCVMN)
- Speaker from Biofarma, Indonesia (TBC)
Innovation and cost reduction in process development and manufacturing of vaccines
- Dr Morena Makhoana, CEO, The Biovac Institute, South Africa
- Dr Hélà Kallel, Head of the Biotechnology Development Group, Institute Pasteur Tunis, Tunisia
- Dr Ahd Hamidi, Project Director, Batavia Biosciences, The Netherlands
- Andrew Clutterbuck, Associate Director MSAT EMEA and Bahar Cebi, Segment Marketing, Process Solutions, Merck
Closing remarks and departure
* Agenda subject to change. More details will be provided ahead of the meeting. Attendance to the Vaccine Manufacturing Forum is limited and available to pharma or biopharma manufacturers and academics only. The offer does not extend to any company that provides pharma or biopharma products or services. We reserve the right to revoke or refuse participation at any time. Attendance is free, though registration is required. Lunch, coffee breaks, cocktails and dinner are provided courtesy of Merck KGaA, Darmstadt, Germany. Travel costs and hotel accommodation are at the expense of the attendees.
Venue Information
Grosvenor House West Marina Beach
Al Emreef Street
Dubai, United Arab Emirates
Organization Committee
Dr Anissa Boumlic
Associate Director Vaccine & Viral Therapies Segment, EMEA
Aziz El Balboul
Head of Middle East and West Africa
Youssef Gaabouri
Head of North Africa & Egypt
Mwai Ngibuini
Head of Sub-Saharian Africa
Dr Youness Cherradi
Vaccine Process Development Network lead, EMEA
Pierre Charlet
Single Use technologies Sales development Specialist, EE & MEA
Olivier Marchal
Systems and Hardware Sales Development Manager, EMEA
Perrine Convard
Administrative assistant
Claudia Polstierna
Administrative assistant